Microplasmin: A Novel Thrombolytic That Improves Behavioral Outcome After Embolic Strokes in Rabbits
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (9) , 2279-2284
- https://doi.org/10.1161/01.str.0000028267.09604.7b
Abstract
Background and Purpose— It has been proposed that the novel thrombolytic microplasmin may be useful in the treatment of ischemic stroke. In the present study the effects and safety profile of micro...Keywords
This publication has 19 references indexed in Scilit:
- Is the promise of randomized control trials ("evidence-based medicine") overstated?Current Neurology and Neuroscience Reports, 2002
- Treatment of acute ischemic strokeAnnals of Emergency Medicine, 2001
- Reducing Bleeding Complications After Thrombolytic Therapy for StrokeCNS Drugs, 2001
- Plasmin Induces Local Thrombolysis without Causing Hemorrhage: A Comparison with Tissue Plasminogen Activator in the RabbitThrombosis and Haemostasis, 2001
- Thrombolytic stroke therapyNeurology, 1999
- Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasminProceedings of the National Academy of Sciences, 1997
- An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse HippocampusJournal of Neuroscience, 1997
- Neuronal cell death and tPANature, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Tissue Plasminogen Activator Reduces Neurological Damage After Cerebral EmbolismScience, 1985